Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses.
Lyudovyk O, Kim JY, Qualls D, Hwee MA, Lin YH, Boutemine SR, Elhanati Y, Solovyov A, Douglas M, Chen E, Babady NE, Ramanathan L, Vedantam P, Bandlamudi C, Gouma S, Wong P, Hensley SE, Greenbaum B, Huang AC, Vardhana SA. Lyudovyk O, et al. Among authors: qualls d. Cancer Cell. 2022 Jul 11;40(7):738-753.e5. doi: 10.1016/j.ccell.2022.05.013. Epub 2022 May 30. Cancer Cell. 2022. PMID: 35679859 Free PMC article.
Retrospective characterization of nodal marginal zone lymphoma.
Stuver R, Drill E, Qualls D, Okwali M, Lee Batlevi C, Caron PC, Dogan A, Epstein-Peterson ZD, Falchi L, Hamlin PA, Horwitz SM, Imber BS, Intlekofer AM, Johnson WT, Khan N, Kumar A, Lahoud OB, Lue JK, Matasar MJ, Moskowitz AJ, Noy A, Owens CN, Palomba ML, Schöder H, Vardhana SA, Yahalom J, Zelenetz AD, Salles G, Straus DJ. Stuver R, et al. Among authors: qualls d. Blood Adv. 2023 Sep 12;7(17):4838-4847. doi: 10.1182/bloodadvances.2022009587. Blood Adv. 2023. PMID: 37307213 Free PMC article. Review.
Optimizing CAR T cell therapy in lymphoma.
Qualls D, Salles G. Qualls D, et al. Hematol Oncol. 2021 Jun;39 Suppl 1:104-112. doi: 10.1002/hon.2844. Hematol Oncol. 2021. PMID: 34105817 Review.
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience.
Palomba ML, Qualls D, Monette S, Sethi S, Dogan A, Roshal M, Senechal B, Wang X, Rivière I, Sadelain M, Brentjens RJ, Park JH, Smith EL. Palomba ML, et al. Among authors: qualls d. J Immunother Cancer. 2022 Feb;10(2):e004128. doi: 10.1136/jitc-2021-004128. J Immunother Cancer. 2022. PMID: 35173030 Free PMC article.
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
Qualls D, Jacobson CA. Qualls D, et al. Blood Adv. 2023 Jul 25;7(14):3469-3471. doi: 10.1182/bloodadvances.2023009834. Blood Adv. 2023. PMID: 37450319 Free PMC article. No abstract available.
A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma.
Qualls D, Lam HY, Whiting K, Kumar A, Matasar M, Owens C, Nichols C, Espeleta JA, Qiu A, Subzwari S, Biggar E, Seshan V, Salles G, Younes A, Batlevi C. Qualls D, et al. Blood Adv. 2022 Sep 27;6(18):5262-5266. doi: 10.1182/bloodadvances.2021006555. Blood Adv. 2022. PMID: 35171976 Free PMC article. Clinical Trial. No abstract available.
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement.
Qualls D, Sullivan A, Li S, Brunner AM, Collier K, Hochberg E, Armand P, Batchelor TT, Chen YB, DeFilipp Z. Qualls D, et al. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):884-888. doi: 10.1016/j.clml.2017.08.100. Epub 2017 Aug 15. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28870642
38 results